Title:
FUSED RING DERIVATIVE USED AS FGFR4 INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2020/020377
Kind Code:
A1
Abstract:
A compound represented by formula I or a pharmaceutically acceptable salt thereof and a use thereof in preparing a drug for treating, stopping, or preventing a disease or disorder mediated by FGFR4 activity.
Inventors:
YANG HONGWEI (CN)
ZHOU RUI (CN)
ZHOU LIANG (CN)
SUN XIN (CN)
ZHOU RUI (CN)
ZHOU LIANG (CN)
SUN XIN (CN)
Application Number:
PCT/CN2019/098076
Publication Date:
January 30, 2020
Filing Date:
July 29, 2019
Export Citation:
Assignee:
JACOBIO PHARMACEUTICALS CO LTD (CN)
International Classes:
C07D471/04; A61K31/4375; A61K31/444; A61P35/00; C07D498/04; C07D519/00
Domestic Patent References:
| WO2017198149A1 | 2017-11-23 | |||
| WO2018028664A1 | 2018-02-15 | |||
| WO2017202390A1 | 2017-11-30 |
Foreign References:
| CN105683188A | 2016-06-15 | |||
| CN107304210A | 2017-10-31 | |||
| CN107304211A | 2017-10-31 | |||
| CN108341815A | 2018-07-31 |
Other References:
"Design of Prodrugs", 1985, ELSEVIER
See also references of EP 3831827A4
See also references of EP 3831827A4
Download PDF:
Previous Patent: REFERENCE SIGNAL SENDING AND RECEIVING METHOD, DEVICE, AND APPARATUS
Next Patent: CHARGER
Next Patent: CHARGER